Tailoring antiviral therapy in chronic hepatitis B patients with lamivudine resistance.
Brunetto
Maurizia Rossana
MR
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives; D000075202:Contraindications; D004305:Dose-Response Relationship, Drug; D024882:Drug Resistance, Viral / Q000235:genetics; D006515:Hepatitis B virus / Q000187:drug effects / Q000378:metabolism; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology / Q000627:therapeutic use*; D063065:Organophosphonates / Q000009:adverse effects
D063065:Organophosphonates; D019259:Lamivudine; C053001:adefovir; D000225:Adenine